Sm Faysal Bellah

Dr. Sm Faysal Bellah

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2023 in Annals of Human Biology
Verified
Journal Article
Open access
SBSm Faysal Bellah
Sm Faysal Bellah
ASAbdus Salam
Abdus Salam
SBS. M. Saker Billah
S. M. Saker Billah
RKRezaul Karim
Rezaul Karim
CYP3A4 and CYP3A5 are biologically potential genes responsible for prostate cancer.We aimed to analyse the expression and association of CYP3A4 and CYP3A5 genes in prostate cancer.Web-based bioinfo...

27 May 2016 in Advances in Traditional Medicine
Verified
Journal Article
Closed access
PDF file
SBSm Faysal Bellah
Sm Faysal Bellah
ASAbdus Salam
Abdus Salam
Md Rezaul KarimMd Rezaul Karim
Md Rezaul Karim
JHJahangir Hossain
Jahangir Hossain
ASAshrafudoulla
Ashrafudoulla

24 February 2024 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
PDF file
SBSm Faysal Bellah
Sm Faysal Bellah
FXFangyuan Xiong
Fangyuan Xiong
ZDZhen Dou
Zhen Dou
FYFengrui Yang
Fengrui Yang
XLXing Liu
Xing Liu
LZLiangyu Zhang
Liangyu Zhang
Stable transmission of genetic information during cell division requires faithful chromosome segregation. Mounting evidence has demonstrated that polo-like kinase 1 (PLK1) dynamics at kinetochores control correct kinetochore–microtubule attachments and subsequent silencing of the spindle assembly checkpoint. However, the mechanisms underlying PLK1-mediated silencing of the spindle checkpoint remain elusive. Here, we identified a regulatory mechanism by which PLK1-elicited zeste white 10 (ZW10) phosphorylation regulates spindle checkpoint silencing in mitosis. ZW10 is a cognate substrate of PLK1, and the phosphorylation of ZW10 at Ser12 enables dynamic ZW10–Zwint1 interactions. Inhibition of ZW10 phosphorylation resulted in misaligned chromosomes, while persistent expression of phospho-mimicking ZW10 mutant caused premature anaphase, in which sister chromatids entangled as cells entered anaphase. These findings reveal the previously uncharacterized PLK1–ZW10 interaction through which dynamic phosphorylation of ZW10 fine-tunes accurate chromosome segregation in mitosis.

3 June 2024 in Journal of Molecular Cell Biology
Verified
Journal Article
Open access
PDF file
SBSm Faysal Bellah
Sm Faysal Bellah
FYFengrui Yang
Fengrui Yang
FXFangyuan Xiong
Fangyuan Xiong
ZDZhen Dou
Zhen Dou
XYXuebiao Yao
Xuebiao Yao
XLXing Liu
Xing Liu
Zeste white 10 (ZW10) was first identified as a centromere/kinetochore protein encoded by the ZW10 gene in Drosophila. ZW10 guides the spindle assembly checkpoint signaling during mitotic chromosome segregation in metazoans. Recent studies have shown that ZW10 is also involved in membranous organelle interactions during interphase and plays a vital role in membrane transport between the endoplasmic reticulum and Golgi apparatus. Despite these findings, the precise molecular mechanisms by which ZW10 regulates interactions between membranous organelles in interphase and the assembly of membraneless organelle kinetochore in mitosis remain elusive. Here, we highlight how ZW10 forms context-dependent protein complexes during the cell cycle. These complexes are essential for mediating membrane trafficking in interphase and ensuring the accurate segregation of chromosomes in mitosis.

1 January 2025 in International Journal of Breast Cancer
Verified
Journal Article
Open access
SBSm Faysal Bellah
Sm Faysal Bellah
AHAlim Hossen
Alim Hossen
SBS. M. Saker Billah
S. M. Saker Billah
NINur Islam
Nur Islam
Background: Breast cancer is a leading cause of cancer‐related morbidity and mortality in women worldwide. Among its subtypes, triple‐negative breast cancer (TNBC) poses the greatest therapeutic challenge due to its aggressive nature and lack of targeted treatments. Holocytochrome c synthase (HCCS), a mitochondrial enzyme essential for cytochrome c maturation, may play a pivotal role in cancer pathogenesis. Objective: This study aimed to investigate the expression profile, epigenetic regulation, immune interactions, prognostic significance, and molecular networks of HCCS across cancers, with a particular focus on breast cancer and its subtypes. Methods: Publicly available datasets and bioinformatics tools were employed to analyze HCCS expression, methylation, survival outcomes, immune infiltration, and interaction networks. Expression and clinical outcomes were examined using TCGA, while methylation and expression patterns were assessed via UALCAN and TNMplot. Survival analyses were performed using Kaplan–Meier Plotter, and immune infiltration was evaluated with TIMER2.0. Protein–protein interaction networks were generated with STRING, and functional enrichment was conducted through g:Profiler. Key findings were validated in independent breast cancer cohorts from GEO and the GOBO platform. Results: HCCS was significantly overexpressed in multiple cancers, with the highest upregulation observed in breast cancer, particularly TNBC. Hypomethylation of the HCCS promoter was associated with increased expression. High HCCS expression correlated with poorer relapse‐free survival and greater immune infiltration, including CD4 + T cells, CD8 + T cells, macrophages (M1/M2), mast cells, and regulatory T cells. Protein–protein interaction analysis revealed HCCS‐associated genes enriched in mitochondrial and apoptotic pathways. Validation across independent datasets consistently supported the association of elevated HCCS expression with poor prognosis in breast cancer. Conclusion: This integrated bioinformatics analysis highlights HCCS as a potential prognostic biomarker and therapeutic target in breast cancer, particularly in TNBC, although further experimental validation is required before clinical application.

1 January 2025 in International Journal of Breast Cancer
Verified
Journal Article
Open access
SBSm Faysal Bellah
Sm Faysal Bellah
FSFatema Akter Sonia
Fatema Akter Sonia
RFRazowanul Ferdous
Razowanul Ferdous
ODOlanrewaju Ayodeji Durojaye
Olanrewaju Ayodeji Durojaye
RIRobiul Islam
Robiul Islam
Background: Breast cancer (BRCA) remains a leading cause of cancer‐related mortality among women. CCL18 and EGF are implicated in tumor biology; however, their roles in BRCA remain partly defined. This study investigates their expression profiles, immune associations, prognostic relevance, epigenetic regulation, and molecular networks. Methods: Expression data from TCGA, UALCAN, and GSCA were analyzed to compare CCL18 and EGF levels in BRCA and normal tissues. Immune infiltration was assessed using TIMER, while survival analyses were performed via Kaplan–Meier plotter and TCGA subcohorts, including menopausal status. Promoter DNA methylation was examined using UALCAN. Gene correlation networks and protein–protein interactions were assessed using UALCAN and STRING. Result: CCL18 was significantly upregulated in BRCA tissues, while EGF showed no consistent increase compared to normal tissue. Both genes were strongly correlated with immune cell infiltration. High CCL18 and EGF expression was associated with reduced relapse‐free survival in BRCA. Promoter regions of both genes exhibited reduced DNA methylation, supporting their elevated expression in tumors. Interaction analyses revealed distinct immune‐ and signaling‐related gene and protein networks. Conclusion: CCL18 shows strong prognostic and immunological relevance in BRCA, while EGF appears to play a broader oncogenic role. Hypomethylation of both genes may drive their aberrant expression and involvement in tumor progression.